Cargando…

Daptomycin-induced eosinophilic pneumonia - a systematic review

PURPOSE: Eosinophilic pneumonia comprises a group of lung diseases in which eosinophils appear in increased numbers in the lungs and sometimes in the bloodstream. Several case reports link daptomycin use to this phenomenon. SUMMARY: We performed a systematic literature review to identify cases of eo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uppal, Priyasha, LaPlante, Kerry L., Gaitanis, Melissa M., Jankowich, Matthew D., Ward, Kristina E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153904/ https://www.ncbi.nlm.nih.gov/pubmed/27999664 http://dx.doi.org/10.1186/s13756-016-0158-8

Ejemplares similares

Daptomycin-induced Acute Eosinophilic Pneumonia
por: Kumar, Sundeep, et al.
Publicado: (2018)

Daptomycin-Induced Acute Eosinophilic Pneumonia
por: Portalatin, Gilda M, et al.
Publicado: (2021)

Daptomycin-Induced Eosinophilic Pneumonia Mimicking Multifocal Pneumonia
por: Abd Algayoum, Randa, et al.
Publicado: (2022)

Factors Associated with Daptomycin-Induced Eosinophilic Pneumonia
por: Ishikawa, Kazuhiro, et al.
Publicado: (2022)

Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature
por: Higashi, Yoshitsugu, et al.
Publicado: (2017)

Acute Eosinophilic Pneumonia Secondary to Daptomycin
por: Somoza-Cano, Francisco J, et al.
Publicado: (2021)

1323. Substantial Doses of Daptomycin and Rifampin Eradicate S. epidermidis Biofilm in an In Vitro Pharmacodynamic (IVPD) Model
por: Piehl, Emily C, et al.
Publicado: (2020)

Daptomycin eosinophilic pneumonia: an adverse effect to be aware of
por: Alonso, Gabriela Abelenda, et al.
Publicado: (2018)

Daptomycin: Acute eosinophilic pneumonia: case report
Publicado: (2021)

Antimicrobial stewardship program prompts increased and earlier infectious diseases consultation
por: Morrill, Haley J, et al.
Publicado: (2014)

Eosinophilic pneumonia: a case of daptomycin induced lung injury
por: Raman, Vaishnavi, et al.
Publicado: (2021)

Daptomycin-Induced Acute Eosinophilic Pneumonia: Late Onset and Quick Recovery
por: Rachid, Mohamad, et al.
Publicado: (2017)

Two patients with daptomycin induced eosinophilic pneumonia with different presentations and treatment
por: Raru, Yonas, et al.
Publicado: (2017)

Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program at a Veterans Affairs Medical Center: A Six-Point Assessment
por: Morrill, Haley J., et al.
Publicado: (2016)

Daptomycin associated eosinophilic pneumonia: case report and differential diagnoses
por: Basnet, Sijan, et al.
Publicado: (2018)

Acute Eosinophilic Pneumonia: A Rare Complication of Daptomycin Therapy
por: Storandt, Michael H, et al.
Publicado: (2020)

Unexpected Outcome of Daptomycin-induced Eosinophilic Pneumonia: Rarity Within a Rarity
por: Raza, Ahmad, et al.
Publicado: (2019)

Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection
por: Soldevila-Boixader, Laura, et al.
Publicado: (2021)

Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature
por: Kalogeropoulos, Andreas S, et al.
Publicado: (2011)

Multifocal Pneumonia Amidst the Global COVID-19 Pandemic: A Case of Daptomycin-Induced Eosinophilic Pneumonia
por: Watts, Abi, et al.
Publicado: (2021)

Assessments of Opportunities to Improve Antibiotic Prescribing in an Emergency Department: A Period Prevalence Survey
por: Timbrook, Tristan T., et al.
Publicado: (2017)

A UNIQUE CASE: ACUTE EOSINOPHILIC PNEUMONIA SECONDARY TO DAPTOMYCIN: A COVID-19 PNEUMONIA MIMIC
por: MEHERN, KAITLYN, et al.
Publicado: (2022)

Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report
por: Eckhardt, Lynda G. J., et al.
Publicado: (2022)

Daptomycin: Acute eosinophilic pneumonitis: case report
Publicado: (2022)

Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Geriak, Matthew, et al.
Publicado: (2019)

Cognitive Biases in the Era of COVID-19 : A Case of Clostridium sporogenes Bacteremia in a Patient with Small Bowel Obstruction
por: Vecchio, Marc J., et al.
Publicado: (2020)

1628. Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia
por: Caffrey, Aisling, et al.
Publicado: (2020)

Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm
por: Pham, Truong-Thanh, et al.
Publicado: (2022)

Virulence profile: Kerry L LaPlante
por: LaPlante, Kerry L
Publicado: (2014)

699. Relationship Between Klebsiella pneumoniae Antimicrobial Resistance and Biofilm Formation
por: Cusumano, Jaclyn, et al.
Publicado: (2018)

Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?
por: Bassukas, Ioannis D., et al.
Publicado: (2016)

470. Concomitant Antibiotic Use and Death Among a National Cohort of Veterans With Clostridium difficile Infection (CDI)
por: Appaneal, Haley, et al.
Publicado: (2018)

Efficacy and safety of daptomycin: systematic review and meta-analysis
por: Rosanova, María Teresa, et al.
Publicado: (2019)

Cisplatin-Induced Eosinophilic Pneumonia
por: Ideguchi, Hideharu, et al.
Publicado: (2014)

Lenalidomide‐induced eosinophilic pneumonia
por: Toma, Andrew, et al.
Publicado: (2017)

Mesalamine induced eosinophilic pneumonia
por: Gupta, Ankit, et al.
Publicado: (2017)

Eosinophilic Syndromes Associated With Daptomycin Use: Re-exposure Hypersensitivity Pneumonitis and Prior Peripheral Eosinophilia
por: West, Katelyn A, et al.
Publicado: (2022)

Real-World Outcomes Associated With Letermovir Use for Cytomegalovirus Primary Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Systematic Review and Meta-analysis of Observational Studies
por: Vyas, Ami, et al.
Publicado: (2022)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Impact of minocycline, polymyxin B, meropenem, and amikacin on growth-prevention of Acinetobacter baumannii with various biofilm-forming capabilities
por: Beganovic, Maya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kkjh7c4tc5mhfqk71tstqlbtnq